Perspectives

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Oncology Outlook for 2025
As has been true for many years, cancer remains the second leading cause of death in developed countries, and oncology remains the largest therapeutic area for biopharma R&D and sales. Accordingly, Lumanity has cultivated dedicated expertise in oncology across our businesses, including strategy consulting, medical affairs, medical communications, market insight, market access, and others. Lumanity has further established an Oncology Center of Excellence where our internal oncology experts across the company coordinate, collaborate, and share insights. As 2024 wrapped up, we reflected on some noteworthy trends and events and how they may continue to unfold and impact the field in 2025. We are pleased to share with you a collection of these perspectives.
Whitepaper Jan 27, 2025

Featured

Oncology Outlook for 2025
As has been true for many years, cancer remains the second leading cause of death in developed countries, and oncology remains the largest therapeutic area for biopharma R&D and sales. Accordingly, Lumanity has cultivated dedicated expertise in oncology across our businesses, including strategy consulting, medical affairs, medical communications, market insight, market access, and others. Lumanity has further established an Oncology Center of Excellence where our internal oncology experts across the company coordinate, collaborate, and share insights. As 2024 wrapped up, we reflected on some noteworthy trends and events and how they may continue to unfold and impact the field in 2025. We are pleased to share with you a collection of these perspectives.
Whitepaper Jan 27, 2025
How to: Undertake a Literature Review
Lumanity’s Andrea Garcia & Khushboo Gurjar explore the two primary approaches to literature reviews highlighting their distinct methodologies, applications and roles in achieving specific research objectives.
Resource